Tag: capital

Hamilton, Bermuda, July 1, 2025 -- Golar LNG Limited (the “Company”) (NASDAQ: GLNG) announced today the closing of its previously announced offering of 2.75% Convertible Senior Notes due 2030 (the “Notes”), in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company sold $575 million aggregate principal amount of the Notes, including $75 million aggregate principal amount of the Notes sold pursuant to the initial purchasers’ exercise in full of their 30-day option to purchase additional Notes in connection with the offering.

PANAMA CITY, July 01, 2025 (GLOBE NEWSWIRE) -- Gate, a globally leading cryptocurrency trading platform, has officially surpassed 30 million registered users, marking a new milestone in its global expansion. This remarkable achievement underscores the platform’s growing influence across international markets and highlights the progress Gate has made in strategic transformation, brand upgrade, and ecosystem development.

JAKARTA, Indonesia, July 01, 2025 (GLOBE NEWSWIRE) -- HR Asia Best Companies to Work for in Asia, owned by Business Media International, proudly honours 80 organizations that exemplify excellence in human capital strategy and workplace culture. This year’s ceremony arrives as Indonesian companies navigate critical challenges in talent retention, multigenerational workforce integration, and shifting employee expectations.

Please see below information about transactions made under the second tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

PRESS RELEASE

Amsterdam, July 1, 2025

LAUSANNE, Switzerland and COPENHAGEN, Denmark, July 01, 2025 (GLOBE NEWSWIRE) -- ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced that the first participant has been included in the company’s Phase 2 clinical trial of its lead candidate RPN-001 (leflutrozole), an orally administered aromatase inhibitor in development for the treatment of male infertility (https://clinicaltrials.gov/study/NCT06993155?term=Leflutrozole&rank=1).

Issy-les-Moulineaux, July 1, 2025 (7am)
Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)